127 related articles for article (PubMed ID: 8640842)
21. Fc gamma RIII (CD16) on human macrophages is a functional product of the Fc gamma RIII-2 gene.
Perussia B; Ravetch JV
Eur J Immunol; 1991 Feb; 21(2):425-9. PubMed ID: 1825635
[TBL] [Abstract][Full Text] [Related]
22. Fc gamma RII, Fc gamma RIII, and CD18 receptors mediate in part neutrophil activation on a plasma coated expanded polytetrafluoroethylene surface.
Katz DA; Haimovich B; Greco RS
Surgery; 1995 Aug; 118(2):154-60; discussion 160-1. PubMed ID: 7638728
[TBL] [Abstract][Full Text] [Related]
23. A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivo.
Hombach A; Jung W; Pohl C; Renner C; Sahin U; Schmits R; Wolf J; Kapp U; Diehl V; Pfreundschuh M
Int J Cancer; 1993 Nov; 55(5):830-6. PubMed ID: 8244580
[TBL] [Abstract][Full Text] [Related]
24. Human Fc gamma RIII (CD16). Isoforms with distinct allelic expression, extracellular domains, and membrane linkages on polymorphonuclear and natural killer cells.
Edberg JC; Redecha PB; Salmon JE; Kimberly RP
J Immunol; 1989 Sep; 143(5):1642-9. PubMed ID: 2474607
[TBL] [Abstract][Full Text] [Related]
25. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
Hadley AG; Zupanska B; Kumpel BM; Leader KA
Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
[TBL] [Abstract][Full Text] [Related]
26. Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (Fc gamma RIII) expressed by human natural killer (NK) cells.
Silla LM; Chen J; Zhong RK; Whiteside TL; Ball ED
Br J Haematol; 1995 Apr; 89(4):712-8. PubMed ID: 7772507
[TBL] [Abstract][Full Text] [Related]
27. G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210).
Repp R; Valerius T; Wieland G; Becker W; Steininger H; Deo Y; Helm G; Gramatzki M; Van de Winkel JG; Lang N
J Hematother; 1995 Oct; 4(5):415-21. PubMed ID: 8581378
[TBL] [Abstract][Full Text] [Related]
28. Surface expression and distribution of Fc receptor III (CD16 molecule) on human natural killer cells and polymorphonuclear neutrophils.
Fernández-Segura E; García JM; López-Escámez JA; Campos A
Microsc Res Tech; 1994 Jul; 28(4):277-85. PubMed ID: 7919518
[TBL] [Abstract][Full Text] [Related]
29. Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report.
Kumpel BM; Beliard R; Brossard Y; Edelman L; de Haas M; Jackson DJ; Kooyman P; Ligthart PC; Monchâtre E; Overbeeke MA; Puillandre P; de Romeuf C; Wilkes AM
Transfus Clin Biol; 2002 Jan; 9(1):45-53. PubMed ID: 11889899
[TBL] [Abstract][Full Text] [Related]
30. Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes.
de Palazzo IG; Gercel-Taylor C; Kitson J; Weiner LM
Cancer Res; 1990 Nov; 50(22):7123-8. PubMed ID: 2146012
[TBL] [Abstract][Full Text] [Related]
31. Comparative efficiencies of bispecific F(ab'gamma)2 and chimeric mouse/human IgG antibodies in recruiting cellular effectors for cytotoxicity via Fc gamma receptors.
Greenman J; Hogg N; Nikoletti S; Slade C; Stevenson G; Glennie M
Cancer Immunol Immunother; 1992; 34(6):361-9. PubMed ID: 1532922
[TBL] [Abstract][Full Text] [Related]
32. Functions of the various IgG Fc receptors in mediating killing of Toxoplasma gondii.
Erbe DV; Pfefferkorn ER; Fanger MW
J Immunol; 1991 May; 146(9):3145-51. PubMed ID: 1826707
[TBL] [Abstract][Full Text] [Related]
33. Different membrane anchors of Fc gamma RIII (CD16) on K/NK-lymphocytes and neutrophils. Protein- vs lipid-anchor.
Ueda E; Kinoshita T; Nojima J; Inoue K; Kitani T
J Immunol; 1989 Aug; 143(4):1274-7. PubMed ID: 2545784
[TBL] [Abstract][Full Text] [Related]
34. Increase of lymphocytes expressing Fc-receptor class III (CD16) by exposure to human seminal plasma.
Thaler CJ; Boldt HD; McIntyre JA; Faulk WP
Fertil Steril; 1994 Jan; 61(1):151-9. PubMed ID: 7507445
[TBL] [Abstract][Full Text] [Related]
35. Tribody [(HER2)
Oberg HH; Kellner C; Gonnermann D; Sebens S; Bauerschlag D; Gramatzki M; Kabelitz D; Peipp M; Wesch D
Front Immunol; 2018; 9():814. PubMed ID: 29725336
[TBL] [Abstract][Full Text] [Related]
36. Antitumor effects of a bispecific antibody targeting CA19-9 antigen and CD16.
Garcia de Palazzo I; Holmes M; Gercel-Taylor C; Weiner LM
Cancer Res; 1992 Oct; 52(20):5713-9. PubMed ID: 1394194
[TBL] [Abstract][Full Text] [Related]
37. Functional capacity of Fc gamma receptor III (CD16) on human neutrophils.
Edberg JC; Salmon JE; Kimberly RP
Immunol Res; 1992; 11(3-4):239-51. PubMed ID: 1287118
[TBL] [Abstract][Full Text] [Related]
38. The glycosylphosphatidylinositol-linked Fc gamma receptor III represents the dominant receptor structure for immune complex activation of neutrophils.
Hundt M; Schmidt RE
Eur J Immunol; 1992 Mar; 22(3):811-6. PubMed ID: 1532149
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of monocyte and polymorphonuclear granulocyte immune phagocytosis by monoclonal antibodies specific for Fc gamma RI, II and III.
Flesch BK; Achtert G; Neppert J
Ann Hematol; 1997 Jan; 74(1):15-22. PubMed ID: 9031610
[TBL] [Abstract][Full Text] [Related]
40. The anti-Fc gamma RIII mAb 3G8 induces neutrophil activation via a cooperative actin of Fc gamma RIIIb and Fc gamma RIIa.
Vossebeld PJ; Homburg CH; Roos D; Verhoeven AJ
Int J Biochem Cell Biol; 1997 Mar; 29(3):465-73. PubMed ID: 9202425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
